Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Nature Medicine|February 16, 2010
An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaBJunxia Min, Alexander Zaslavsky, Giuseppe Fedele, et al.
Cancer Cell|April 4, 2020
A Deregulated HOX Gene Axis Confers an Epigenetic Vulnerability in KRAS-Mutant Lung CancersStephanie L Guerra, Ophélia Maertens, Ryan Kuzmickas, et al.
Sarcoma|February 25, 2020
Targeting Refractory Sarcomas and Malignant Peripheral Nerve Sheath Tumors in a Phase I/II Study of Sirolimus in Combination with Ganetespib (SARC023)AeRang Kim, Yao Lu, Scott H Okuno, et al.
Genes, Chromosomes & Cancer|October 12, 2011
Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumorsEline Beert, Hilde Brems, Bruno Daniëls, et al.
Cancer Discovery|February 3, 2019
MAPK Pathway Suppression Unmasks Latent DNA Repair Defects and Confers a Chemical Synthetic Vulnerability in <i>BRAF-, NRAS</i>-, and <i>NF1</i>-Mutant MelanomasOphélia Maertens, Ryan Kuzmickas, Haley E Manchester, et al.
Cancer Cell|September 13, 2011
Exploiting cancer cell vulnerabilities to develop a combination therapy for ras-driven tumorsThomas De Raedt, Zandra Walton, Jessica L Yecies, et al.
Sarcoma|August 21, 2019
Targeting Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST) in a Phase II Study of Everolimus in Combination with Bevacizumab (SARC016)Brigitte C Widemann, Yao Lu, Denise Reinke, et al.
The Journal of Clinical Investigation|June 9, 2026
Epigenetic and oncogenic inhibitors converge to drive a metabolic catastrophe in castration-resistant prostate cancerRhea Sahu, Miriam Enos, Swastika Sharma, et al.
Cancer Research|July 18, 2024
Targeting Cholesterol Biosynthesis with Statins Synergizes with AKT Inhibitors in Triple-Negative Breast CancerAlissandra L Hillis, Timothy D Martin, Haley E Manchester, et al.
Acta Neuropathologica|November 16, 2011
Neurofibromatosis 2011: a report of the Children's Tumor Foundation annual meetingMichel Kalamarides, Maria T Acosta, Dusica Babovic-Vuksanovic, et al.
Pageof 6